Log in

Relevant bibliographies by topics / Progressiva / Journal articles

To see the other types of publications on this topic, follow the link: Progressiva.

Journal articles on the topic 'Progressiva'

Author: Grafiati

Published: 10 September 2021

Last updated: 17 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Progressiva.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Hirano, Stefanie A., and Valerie M. Harvey. "From progressive symmetric erythrokeratoderma to erythrokeratoderma variabilis progressiva." Journal of the American Academy of Dermatology 64, no. 5 (2011): e81-e82. http://dx.doi.org/10.1016/j.jaad.2010.07.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Chudasama, Shilpa, Prinal Dadhania, and Mahesh Makvana. "Fibrodysplasia Ossificans Progressiva: A Case Report." International Journal of Science and Research (IJSR) 10, no. 1 (2021): 1155–59. https://doi.org/10.21275/sr21120121557.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

HENSCHEN, S. E. "Hemiatrophia progressiva." Nordiskt Medicinskt Arkiv 15, no. 4 (2009): 1–16. http://dx.doi.org/10.1111/j.0954-6820.1883.tb01235.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Beber, Bárbara Costa, Lenisa Brandão, and Márcia Lorena Fagundes Chaves. "Alerta à comunidade fonoaudiológica brasileira sobre a importância da atuação científica e clínica na afasia progressiva primária." CoDAS 27, no. 5 (2015): 505–8. http://dx.doi.org/10.1590/2317-1782/20152015081.

Full text

Abstract:

RESUMO Este artigo tem como objetivo alertar a comunidade científica fonoaudiológica brasileira sobre a importância e necessidade da atuação científica e clínica a respeito da Afasia Progressiva Primária. Esse alerta é fundamentado em um levantamento bibliográfico sistemático da produção científica brasileira sobre Afasia Progressiva Primária, a partir do qual foram encontrados nove artigos brasileiros. Percebe-se que há uma evidente escassez de estudos sobre o tema, pois todos os artigos encontrados foram publicados em periódicos da área médica e boa parte deles foi composta por amostras pequenas, sendo que dois descreveram a efetividade da reabilitação fonoaudiológica de pacientes com Afasia Progressiva Primária. São discutidas perspectivas futuras na área, bem como características da terapia fonoaudiológica para Afasia Progressiva Primária. Concluiu-se que é evidente a necessidade de uma maior atuação da fonoaudiologia nas Afasias Progressivas Primárias.

APA, Harvard, Vancouver, ISO, and other styles

5

Eregie, Charles O., and Valerie Bekederemo. "A case report of rapidly progressive fibrodysplasia (myositis) ossificans progressiva." Annals of Tropical Paediatrics 17, no. 3 (1997): 289–92. http://dx.doi.org/10.1080/02724936.1997.11747900.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Xie, Chen, Xiao Liu, Wenbao Li, Zhaozhe Yao, Hongyue Men, and Zongyu Li. "The role of miRNAs as biomarkers in heterotopic ossification." EFORT Open Reviews 9, no. 12 (2024): 1120–33. https://doi.org/10.1530/eor-22-0100.

Full text

Abstract:

Fibrodysplasia ossificans progressiva and progressive osseous heteroplasia are genetic forms of heterotopic ossification (HO). Fibrodysplasia ossificans progressiva is caused by ACVR1 gene mutations, while progressive osseous heteroplasia is caused by GNAS gene mutations. Nongenetic HO typically occurs after trauma or surgery, with an occurrence rate of 20–60%. It can also be observed in conditions such as diffuse idiopathic skeletal hyperostosis, spinal ligament ossification, ankylosing spondylitis, and skeletal fluorosis. The exact cause of nongenetic HO is not entirely clear. More than 100 types of miRNAs have been identified as being linked to the development of HO. Some miRNAs are promising potential biomarkers for traumatic HO and ossification of the posterior longitudinal ligament. These findings further emphasize the significant role miRNAs play in the pathogenesis and progression of bone disorders. Repeated investigations into the function of a specific miRNA are infrequent and yield inconsistent results, possibly because of variable experimental conditions. It is hypothesized that miRNAs can enhance osteogenesis for the management of fractures and bone defects. However, further research is required to validate this hypothesis.

APA, Harvard, Vancouver, ISO, and other styles

7

Trebisacce, Romina, Victoria Ferrero, and Renato Miguel Basso. "Flavors of the progressive in the New Romania: the perfective progressive periphrasis in Brazilian Portuguese and Argentinian Spanish / Sabores do progressivo na România Nova: a perífrase perfectiva progressivo no português brasileiro e no espanhol argentino." REVISTA DE ESTUDOS DA LINGUAGEM 29, no. 3 (2021): 2079. http://dx.doi.org/10.17851/2237-2083.29.3.2079-2115.

Full text

Abstract:

Abstract: In this paper, we analyze the perfective progressive periphrasis (PPP) in Brazilian Portuguese (BrP) and Argentinian Spanish (AS) in a comparative way. Based on different linguistic tests, we make two statements regarding the PPP in comparison with the imperfective progressive periphrasis (IPP). Firstly, we claim that the PPP has a progressive and perfective meaning. Secondly, we claim that the PPP allows iterative readings when combined with telic events (i.e., achievements in BrP and AS and accomplishments just in AS). We propose a syntactic and semantic analysis which accounts for these observations in a compositional way: while the gerund form expresses a progressive meaning (present in both periphrases), the auxiliary on the PPP expresses a perfective meaning which allows the iterative readings observed in this periphrasis.Keywords: verbal aspect; actionality; periphrasis; semantics; syntax.Resumo: Neste artigo, analisamos a perífrase perfectiva progressiva (PPP) no português brasileiro (PB) e no espanhol argentino (EA), de modo comparativo. Baseado em testes linguísticos, fazemos duas afirmações sobre a PPP em comparação com a perífrase imperfectiva progressiva. Em primeiro lugar, afirmamos que a PPP tem significado progressivo e perfectivo. Em segundo lugar, afirmamos que a PPP permite leituras iterativas quando combinada com eventos télicos (achievements no PB e no EA e accomplishments somente no EA). Propomos uma análise sintático-semântica que dá conta dessas observações de um modo composicional: ao passo que a forma do gerúndio expressa o significado progressivo (presente em ambas as perífrases), o auxiliar na PPP expressão um significado perfectivo que permite a leitura iterativa observada nessa perífrase.Palavras-chave: aspecto verbal; acionalidade; perífrase; semântica; sintaxe.

APA, Harvard, Vancouver, ISO, and other styles

8

Acharya, Sudeep, Sandhya Joshi, and Rajib Chaulagain. "Fibrodysplasia Ossificans Progressiva: A Case Report." Journal of Nepal Health Research Council 16, no. 2 (2018): 245–47. http://dx.doi.org/10.3126/jnhrc.v16i2.20319.

Full text

Abstract:

Fibrodysplasia ossificans progressiva is a genetic disorder of the connective tissue differentiation characterized by congenital malformation of the big toes and progressive heterotopic ossification in the extra skeletal tissues like tendons, ligaments, fascia and skeletal muscles leading to permanent disability. The prevalence is one in two million people. During childhood, it may be asymptomatic but in later life, progressive stiffness of major joints renders movement of the individual impossible. Currently, there is no effective treatment for this debilitating disease. Here, we present a case of 27 year old male with clinical and radiological features of fibrodysplasia ossificans progressiva.

APA, Harvard, Vancouver, ISO, and other styles

9

M, Sharique, Yasir Salam Siddiqui,, Mazhar Abbas Julfiqar, and Sherwani MKA. "Fibrodysplasia ossificans progressiva - a case report with brief literature review." MOJ Orthopedics & Rheumatology 12, no. 6 (2020): 132–35. http://dx.doi.org/10.15406/mojor.2020.12.00536.

Full text

Abstract:

Fibrodysplasia ossificans progressiva (FOP) is an exceptionally uncommon autosomal dominant genetic disorder characterized by defects in skeletogenesis manifesting as congenital malformations of the great toes and progressive postnatal induction of disabling ectopic endochondral osteogenesis. During early course of disease patients of FOP are often misdiagnosed as having soft tissue sarcoma or aggressive juvenile fibromatosis and hence sometimes undergo invasive procedures that usually lead to the speeding up of disease process. Therefore early correct diagnosis of fibrodysplasia ossificans progressiva is necessary to prevent additional iatrogenic insult. The case study is being presented to highlight the clinical features of fibrodysplasia ossificans progressiva, difficult aspect of diagnosis and management with brief literature review.

APA, Harvard, Vancouver, ISO, and other styles

10

Zargar, Abdul H., Bashir A. Laway, Shariq R. Masoodi, Arshad I. Wani, Mir I. Bashir, and Muzaffar M. Wani. "Fibrodysplasia Ossificans Progressiva." Annals of Saudi Medicine 19, no. 6 (1999): 525–26. http://dx.doi.org/10.5144/0256-4947.1999.525.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Choi, In Ho, Chin Youb Chung, Tae Joon Cho, et al. "Fibrodysplasia Ossificans Progressiva." Journal of the Korean Orthopaedic Association 33, no. 4 (1998): 1069. http://dx.doi.org/10.4055/jkoa.1998.33.4.1069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Majmudar, DK, NN Hathila, KB Vaishya, Sayani, AV Trivedi, and JG Kalola. "Fibrodysplasia ossificans progressiva." Indian Journal of Radiology and Imaging 15, no. 3 (2005): 347. http://dx.doi.org/10.4103/0971-3026.29152.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Ferraz, Maria Elisabeth Matta de Rezende. "Atrofia Muscular Progressiva." Revista Neurociências 5, no. 1 (1999): 47–48. http://dx.doi.org/10.34024/rnc.1997.v5.8993.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Pinto, Roberta Arb Saba Rodrigues, João Norberto Stávale, Roberto Gomes Nogueira, and Alberto Alain Gabbai. "Leucoencefalopatia Multifocal Progressiva." Revista Neurociências 6, no. 2 (1998): 96–98. http://dx.doi.org/10.34024/rnc.1998.v6.10337.

Full text

Abstract:

Leucoencefalopatia multifocal progressiva (LMP) é uma doença desmielinizante do sistema nervoso central (SNC) causada pelo JC vírus e que acomete indivíduos imunossuprimidos. Neste trabalho apresentamos o quadro clínico e radiológico, a evolução, os diagnósticos diferenciais e os achados anatomopatológicos de um paciente HIV positivo que desenvolveu LMP.

APA, Harvard, Vancouver, ISO, and other styles

15

Carrilho, Paulo Eduardo Mestrineffi, and Egberto Reis Barbosa. "Paralisia Supranuclear Progressiva." Revista Neurociências 7, no. 2 (1999): 54–56. http://dx.doi.org/10.34024/rnc.1999.v7.8958.

Full text

Abstract:

A paralisia supranuclear progressiva (PSP) 6 uma das mais frequentes tormas de parkinsonismo-plus. Foi descrita no inicio da década de 60 por pesquisadores da Universidade de Toronto (Canada) e tem prevaléncia cerca de 100 vezes menor que a da doença de Parkinson. A PSP pertence ao numeroso grupo de doenças degenerativas do sistema nervoso central, cuja etiologia ainda 6 desconhecida. Contudo, nas últimas décadas surgiram alguns novos e interessantes dados relacionados aos mecanismos etiopatogénicos presentes nessa intrigante moléstia. Neste artigo os autores revisam e analisam essas informações.

APA, Harvard, Vancouver, ISO, and other styles

16

Acosta, Carlos Enrique Suárez, and Esperanza Romero Fernández. "Fibrodysplasia Ossificans Progressiva." JCR: Journal of Clinical Rheumatology 27, no. 8S (2021): S858. http://dx.doi.org/10.1097/rhu.0000000000000494.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Tonholo-Silva, Edward R., Elza Aquimi Adachi, Maria Salete Tafner, and Lucia Yoshinaga. "Fibrodisplasia ossificante progressiva." Arquivos de Neuro-Psiquiatria 52, no. 1 (1994): 100–102. http://dx.doi.org/10.1590/s0004-282x1994000100020.

Full text

Abstract:

Fibrodisplasia (miosite) ossificante progressiva (FOP) é doença rara, de herança autossômica dominante, na qual ocorre ossificação ectópica progressiva e malformação esquelética, principalmente no tecido conectivo dos músculos. O diagnóstico é baseado nos achados clínicos e demonstração radiologica das malformações esqueléticas. Relatamos o caso de uma menina de 5 anos de idade com FOP.

APA, Harvard, Vancouver, ISO, and other styles

18

Akyuz, Gulseren, Kardelen Gencer-Atalay, and Pinar Ata. "Fibrodysplasia ossificans progressiva." Current Opinion in Pediatrics 31, no. 6 (2019): 716–22. http://dx.doi.org/10.1097/mop.0000000000000802.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

NEWTON, M. C., P. W. ALLEN, and D. C. RYAN. "FIBRODYSPLASIA OSSIFICANS PROGRESSIVA." British Journal of Anaesthesia 64, no. 2 (1990): 246–50. http://dx.doi.org/10.1093/bja/64.2.246.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Herman, T. E. "Fibrodysplasia ossificans progressiva." Journal of Medical Genetics 31, no. 1 (1994): 85. http://dx.doi.org/10.1136/jmg.31.1.85-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Mitschang, C., and T. Görge. "Purpura pigmentosa progressiva." Phlebologie 46, no. 06 (2017): 358–60. http://dx.doi.org/10.12687/phleb2400-6-2017.

Full text

Abstract:

ZusammenfassungDie Purpura pigmentosa progressiva (PPP) ist eine benigne, häufig chronisch rezidivierende Dermatose, die sich vor allem symmetrisch an den unteren Extremitäten, in ausgeprägten Fällen auch am Rumpf und den oberen Extremitäten, manifestiert. Auch einmalige Krankheitsverläufe sind beschrieben. Klinisch äußert sich die Purpura pigmentosa progressiva in der Akutphase in Form von meist asymptomatischen petechialen Einblutungen, in ihrem Verlauf mit bräunlich-orangenen Maculae. In einigen Fällen wird von einem geringen Juckreiz berichtet. Meist führt der ästhetische Aspekt zum Arztbesuch. Es werden in der Literatur verschiedene Ursachen diskutiert, der genaue Pathomechanismus ist jedoch unklar. Eine zugrundeliegende Systemerkrankung liegt nicht vor. Histologisch zeigen sich Erythrozytenextravasate, perivaskuläre Lymphozyteninfiltrate und Hämosiderinablagerungen ohne Zeichen einer Vaskulitis. Differenzialdiagnostisch kommen vor allem eine leukozytoklastische Vaskulitis oder Gerinnungsstörungen in Betracht. Therapeutisch empfiehlt sich die Gabe von Vitamin C in Kombination mit Rutosid.

APA, Harvard, Vancouver, ISO, and other styles

22

Grimaldi, S., L. Koric, and A. Eusebio. "Paralisi sopranucleare progressiva." EMC - Neurologia 24, no. 4 (2024): 1–10. http://dx.doi.org/10.1016/s1634-7072(24)49601-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Haber, Richard M., and Wedad Hanna. "Epidermolysis bullosa progressiva." Journal of the American Academy of Dermatology 16, no. 1 (1987): 195–200. http://dx.doi.org/10.1016/s0190-9622(87)80061-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

ANAND, SS, and P. JOSHI. "FIBRODYSPLASIA OSSIFICANS PROGRESSIVA." Medical Journal Armed Forces India 51, no. 3 (1995): 213–14. http://dx.doi.org/10.1016/s0377-1237(17)30969-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Stankoff, B., A. Tourbah, Y. Taoufik, and J. Gasnault. "Leucoencefalopatia multifocale progressiva." EMC - Neurologia 10, no. 3 (2010): 1–9. http://dx.doi.org/10.1016/s1634-7072(10)70495-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Maillart, E., Y. Taoufik, J. Gasnault, and B. Stankoff. "Leucoencefalopatia multifocale progressiva." EMC - Neurologia 18, no. 2 (2018): 1–10. http://dx.doi.org/10.1016/s1634-7072(18)89404-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Lagarde, J., V. Hahn, and M. Sarazin. "Afasia primaria progressiva." EMC - Neurologia 19, no. 2 (2019): 1–13. http://dx.doi.org/10.1016/s1634-7072(19)42020-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Ganguly, Sutapa, Dilip Kumar Paul, Bhaswati Ghosal, and Awdesh Choube. "Fibrodysplasia ossificans progressiva." Indian Journal of Pediatrics 61, no. 4 (1994): 417–21. http://dx.doi.org/10.1007/bf02751906.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Stefanova, I., C. Grünberg, and G. Gillessen-Kaesbach. "Fibrodysplasia ossificans progressiva." medizinische genetik 24, no. 1 (2012): 20–32. http://dx.doi.org/10.1007/s11825-012-0315-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Subramanyam, L., Kalpana Gowrishankar, So Shivbalan, and A. Balachandran. "Fibrodysplasia ossificans progressiva." Indian Journal of Pediatrics 71, no. 6 (2004): 563–64. http://dx.doi.org/10.1007/bf02724306.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Iber, T., S. Klösel, B. Schoenes, and K. Zacharowski. "Fibrodysplasia ossificans progressiva." Der Anaesthesist 59, no. 6 (2010): 535–38. http://dx.doi.org/10.1007/s00101-010-1707-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Tavare, Aniket N., and Jane Young. "Fibrodysplasia Ossificans Progressiva." JCR: Journal of Clinical Rheumatology 21, no. 6 (2015): 318. http://dx.doi.org/10.1097/rhu.0000000000000283.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Agrawal, Sumeet, Parashar Ghosh, Amita Aggarwal, and Ramnath Misra. "Fibrodysplasia Ossificans Progressiva." JCR: Journal of Clinical Rheumatology 13, no. 4 (2007): 234. http://dx.doi.org/10.1097/rhu.0b013e31812e00db.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Mahboubi, S., David L. Glaser, Eileen M. Shore, and Frederick S. Kaplan. "Fibrodysplasia ossificans progressiva." Pediatric Radiology 31, no. 5 (2001): 307–14. http://dx.doi.org/10.1007/s002470100447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Kumar, Rajiv Ranjan, Sauvik Dasgupta, Shiv Kumar Suman, and Uma Kumar. "Fibrodysplasia ossificans progressiva." Rheumatology 59, no. 7 (2019): 1789. http://dx.doi.org/10.1093/rheumatology/kez479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Waller, SL, DE Porter, and JS Huntley. "Myositis ossificans progressiva." British Journal of Hospital Medicine 67, no. 11 (2006): 606–7. http://dx.doi.org/10.12968/hmed.2006.67.11.22231.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Al-Zaid, Tariq J. "Fibrodysplasia ossificans progressiva." Pathology 46 (2014): S10. http://dx.doi.org/10.1097/01.pat.0000454080.86299.b1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Doll, G., and J. Grimm. "Myositis ossificans progressiva." RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 156, no. 02 (1992): 202–4. http://dx.doi.org/10.1055/s-2008-1032867.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Gorbatsch, Stephanie, and Benjamin Khan Durani. "Purpura pigmentosa progressiva." hautnah dermatologie 33, no. 4 (2017): 8. http://dx.doi.org/10.1007/s15012-017-2452-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

H. Stark, William. "Myositis ossificans progressiva." Journal of Clinical Anesthesia 3, no. 5 (1991): 429. http://dx.doi.org/10.1016/0952-8180(91)90193-q.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Kaplan, Frederick S., Martine Le Merrer, David L. Glaser, et al. "Fibrodysplasia ossificans progressiva." Best Practice & Research Clinical Rheumatology 22, no. 1 (2008): 191–205. http://dx.doi.org/10.1016/j.berh.2007.11.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Eisler, Lindsay, Robert Tibesar, and James Sidman. "Fibrodysplasia Ossificans Progressiva." Laryngoscope 121, S5 (2011): S341. http://dx.doi.org/10.1002/lary.22297.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Hughes, Andrew, Fergal Monsell, and Martin Gargan. "Fibrodysplasia ossificans progressiva." Current Orthopaedics 22, no. 1 (2008): 48–51. http://dx.doi.org/10.1016/j.cuor.2008.01.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Hampton, F., and G. Ofori-Amanfo. "A Familial Case of Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva)." Tropical Doctor 28, no. 2 (1998): 108–9. http://dx.doi.org/10.1177/004947559802800222.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

CORFIELD, L., R. HAMPTON, and C. J. MCCULLOUGH. "Wrist Arthrodesis Following Ulnar Bar Excision in Fibrodysplasia Ossificans Progressiva." Journal of Hand Surgery 25, no. 2 (2000): 223–24. http://dx.doi.org/10.1054/jhsb.2000.0364.

Full text

Abstract:

Fibrodysplasia ossificans progressiva is a rare disorder characterized by the progressive development of heterotopic bone in the connective tissues of skeletal muscle, ligaments and tendons. Surgical trauma is one of the most potent stimuli for ossification and surgical treatment is generally considered to be contraindicated in this condition. We report a good functional result in a patient with severe hand disability secondary to an ulna-carpal bar in fibrodysplasia ossificans progressiva.

APA, Harvard, Vancouver, ISO, and other styles

46

Acharya, Sudeep, Sandhya Joshi, and Rajib Chaulagain. "Fibrodysplasia Ossificans Progressiva: A Case Report." Journal of Nepal Health Research Council 16, no. 2 (2018): 245–47. http://dx.doi.org/10.33314/jnhrc.v16i2.1193.

Full text

Abstract:

Fibrodysplasia ossificans progressiva is a genetic disorder of the connective tissue differentiation characterized by congenital malformation of the big toes and progressive heterotopic ossification in the extra skeletal tissues like tendons, ligaments, fascia and skeletal muscles leading to permanent disability. The prevalence is one in two million people. During childhood, it may be asymptomatic but in later life, progressive stiffness of major joints renders movement of the individual impossible. Currently, there is no effective treatment for this debilitating disease. Here, we present a case of 27 year old male with clinical and radiological features of fibrodysplasia ossificans progressiva.Keywords: Fibrodysplasia ossificans progressive; heterotopic ossification; myositis ossificans; myositis ossificans progressive.

APA, Harvard, Vancouver, ISO, and other styles

47

Kolondaev, Aleksandr F., and Svetlana S. Rodionova. "Fibrodysplasia ossificans progressiva (clinical observation with a brief review of the literature)." N.N. Priorov Journal of Traumatology and Orthopedics 31, no. 2 (2024): 203–16. http://dx.doi.org/10.17816/vto623695.

Full text

Abstract:

BACKGROUND: Fibrodysplasia ossificans progressiva is a rare genetically determined disease of the musculoskeletal system and characterized by heterotopic ossifications in the muscles, fascia, and tendons and congenital and skeletal deformities that form during life. Owing to the lack of awareness of doctors, unresolved challenges in monitoring the disease and predicting the course and development of its complications, and the lack of generally accepted effective treatment, fibrodysplasia ossificans progressiva leads to severe disability and social disadaptation, limiting the life expectancy of patients. CLINICAL CASE DESCRIPTION: The characteristic anamnestic data of a patient with fibrodysplasia ossificans progressiva are presented. The course of the disease from the moment of detection at age 1 year and 3 months to 29 years was determined. Notably, the care and symptomatic treatment performed during this period could not prevent the regular appearance of new heterotopic ossifications, which led to severe functional disorders and loss of the patient’s ability to self-care. In a brief review, the current possibilities of pathogenetic therapy for this disease and prevention of progression and complications were considered. The risks of unjustified surgical interventions leading to increased severity of the course and functional disorders are emphasized. CONCLUSION: The scientific studies conducted in recent years to examine the etiopathogenesis of fibrodysplasia ossificans progressiva enabled the development of effective pharmacotherapy, which provides hope for the possibility of preventing the progression of the disease and improving the quality of life and social adaptation of patients with fibrodysplasia ossificans progressiva.

APA, Harvard, Vancouver, ISO, and other styles

48

Teichmann, M. "Afasia progressiva non fluente/agrammatica e aprassia della parola primaria progressiva." EMC - Neurologia 24, no. 3 (2024): 1–9. http://dx.doi.org/10.1016/s1634-7072(24)49340-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Muglu, Javaid A., Aditya Garg, T. Pandiarajan, et al. "Pregnancy in fibrodysplasia ossificans progressiva." Obstetric Medicine 5, no. 1 (2011): 35–38. http://dx.doi.org/10.1258/om.2011.110042.

Full text

Abstract:

Fibrodysplasia ossificans progressiva (FOP) is a rare disabling genetic disorder characterized by progressive postnatal heterotopic ossification leading to cumulative disability. Heterotopic bone formation in FOP usually begins in early childhood following a series of painful, post-traumatic, inflammatory soft-tissue swellings known as flare-ups, which later undergo ossification resulting in the progressive immobilization of the chest wall, limbs and jaw by early adulthood. Pregnancy in FOP has occurred infrequently and reproductive decisions are a dilemma for an individual or couple with FOP. We present the clinical course, medical management and potential concerns of four cases of pregnancy in FOP.

APA, Harvard, Vancouver, ISO, and other styles

50

Gubert, Flavia Piccinin Paz, and Marcelo Wordell Gubert. "Tributação progressiva como sanção política na prevenção de danos ambientais em busca de um desenvolvimento sustentável." Núcleo do Conhecimento 03, no. 09 (2023): 144–61. https://doi.org/10.32749/nucleodoconhecimento.com.br/lei/tributacao-progressiva.

Full text

Abstract:

O artigo busca analisar a possibilidade de utilização da progressividade tributária como instrumento de sanção política na prevenção de danos ambientais para um desenvolvimento sustentável. A pesquisa aborda a função social do tributo e a possibilidade da progressividade tributária, bem como a possibilidade da sanção política como meio inibidor do dano ambiental através do princípio da prevenção. Na sequência, trata da análise da interferência do Estado no domínio econômico e o desenvolvimento sustentável. A escolha do tema se justifica diante da necessidade de buscar alternativas para efetivar o desenvolvimento de forma sustentável. Na condução desta pesquisa, adotou-se uma abordagem metodológica baseada no método dialético e dedutivo. A combinação desses métodos permitirá uma análise aprofundada e abrangente das interações complexas entre a progressividade tributária, a sanção política e a prevenção de danos ambientais para alcançar o desenvolvimento sustentável. A coleta de dados consistirá em revisão bibliográfica e documental de fontes primárias e secundárias relacionadas à progressividade tributária, sanção política, prevenção de danos ambientais e desenvolvimento sustentável. Após a coleta de dados, as informações serão organizadas e classificadas em categorias relevantes, considerando a função social do tributo, a progressividade tributária, os princípios da sanção política e da prevenção ambiental. Nessa etapa, busca-se identificar padrões e tendências relacionados à utilização de medidas tributárias como sanção política para promover ações preventivas em prol do desenvolvimento sustentável, serão exploradas as conexões e contradições entre a aplicação da progressividade tributária como sanção política e sua efetividade na prevenção de danos ambientais. Essa análise permitirá compreender as implicações da utilização dessa abordagem para alcançar um desenvolvimento sustentável mais efetivo. Conclui-se que a progressividade tributária se caracteriza como mais um fator a ser utilizado na busca de um desenvolvimento sustentável, em uma atuação preventiva dos danos ambientais.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!